China Government Report On Drug Regulation Seeks To Increase Transparency
This article was originally published in PharmAsia News
Executive Summary
BEIJING - As part of a drive to open China's drug regulatory system to public scrutiny and foster international cooperation, the Chinese government has released a ground-breaking report on the current state of its industry oversight
You may also be interested in...
Beijing’s New Fast-track Review For Innovative Medicines Might Be Open Only To Made-in-China Drugs
BEIJING - China's fast-track review process for certain classes of new drugs, unveiled earlier this month, marks an advance in the country's budding support for innovative medicines, but also might be open only to domestically made products, according to Chinese and American lawyers
Beijing’s New Fast-track Review For Innovative Medicines Might Be Open Only To Made-in-China Drugs
BEIJING - China's fast-track review process for certain classes of new drugs, unveiled earlier this month, marks an advance in the country's budding support for innovative medicines, but also might be open only to domestically made products, according to Chinese and American lawyers
China Recalls Contaminated TCM Injection
SHANGHAI - China has ordered a recall of two batches of acanthopanax-based injections, also know as Siberian ginseng, after reports of serious adverse reactions that caused the death of three patients in Yunan Province, China's Ministry of Health announced Oct. 11